FR2364925A1 - Procede de production d'albumine de serum et nouveau produit ainsi obtenu - Google Patents

Procede de production d'albumine de serum et nouveau produit ainsi obtenu

Info

Publication number
FR2364925A1
FR2364925A1 FR7728189A FR7728189A FR2364925A1 FR 2364925 A1 FR2364925 A1 FR 2364925A1 FR 7728189 A FR7728189 A FR 7728189A FR 7728189 A FR7728189 A FR 7728189A FR 2364925 A1 FR2364925 A1 FR 2364925A1
Authority
FR
France
Prior art keywords
serum albumin
albumin
production process
new product
albumin production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7728189A
Other languages
English (en)
Other versions
FR2364925B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of FR2364925A1 publication Critical patent/FR2364925A1/fr
Application granted granted Critical
Publication of FR2364925B1 publication Critical patent/FR2364925B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Procédé de production d'albumine de sérum et nouveau produit ainsi obtenu. Une fraction d'albumine de sérum est préparée avec un rendement élévé et une pureté élevée, par mise en contact avec une matière polymère resineuse ayant une capacité élevée pour l'adsorption de l'albumine, par chauffage à 65-72 degrés C pendant 1-4 h, tout en maintenant un pH de 5,0 -5,5 puis élution sélective de l'albumine à partir d'un mélange de résine-protéine à un pH de 3,5-4,5; les matières polymères résineuses sont des polymères de dextrane réticulés, substitués par un groupe dialkyl (inférieur) aminoalkyle inférieur. La présente invention est particulièrement utile pour fournir une fraction d'albumine de sérum préparée avec un rendement et une puretée élevés, à partir de plasma ou d'autres fractions de proteines du sang contenant de l'albumine.
FR7728189A 1976-09-20 1977-09-19 Procede de production d'albumine de serum et nouveau produit ainsi obtenu Granted FR2364925A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/724,438 US4075197A (en) 1976-09-20 1976-09-20 Serum albumin production

Publications (2)

Publication Number Publication Date
FR2364925A1 true FR2364925A1 (fr) 1978-04-14
FR2364925B1 FR2364925B1 (fr) 1980-04-25

Family

ID=24910442

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7728189A Granted FR2364925A1 (fr) 1976-09-20 1977-09-19 Procede de production d'albumine de serum et nouveau produit ainsi obtenu

Country Status (7)

Country Link
US (1) US4075197A (fr)
JP (1) JPS6034522B2 (fr)
BE (1) BE858893A (fr)
CH (1) CH633809A5 (fr)
DE (1) DE2742150A1 (fr)
FR (1) FR2364925A1 (fr)
SE (1) SE442588B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
HUT40311A (en) * 1983-06-03 1986-12-28 Kiskunhalasi Aag Process for producing protein concentrates, blood-curd and nutriments from blood and its elements
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
JPS63119235U (fr) * 1987-01-27 1988-08-02
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US5277818A (en) * 1988-10-31 1994-01-11 The Green Cross Corporation Albumin preparation and process for preparing the same
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
AU2010215959A1 (en) 2009-02-20 2011-08-04 Ventria Bioscience Cell culture media containing combinations of proteins
EA039316B1 (ru) * 2016-10-24 2022-01-12 Алкахест, Инк. Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением
JP7504090B2 (ja) 2018-10-26 2024-06-21 アルカヘスト，インコーポレイテッド 疼痛、創傷治癒及び術後回復の改善のための血漿及び血漿画分の使用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2322871A1 (fr) * 1975-09-08 1977-04-01 New Zealand Inventions Dev Procede d'isolement d'albumine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2705230A (en) * 1949-09-23 1955-03-29 Allen F Reid Method of purifying albumin
US2765299A (en) * 1952-06-27 1956-10-02 Armour & Co Recovery of serum albumin
US2958628A (en) * 1957-02-21 1960-11-01 Cutter Lab Heat treatable plasma protein product and method of preparation
US3100737A (en) * 1958-02-05 1963-08-13 Auerswald Wilhelm Method of preparing a plasma protein solution free of active hepatitis virus and product produced thereby
US3555001A (en) * 1969-05-29 1971-01-12 Monsanto Co Process for the fractionation of plasma and serum using water-insoluble polyelectrolytes containing diloweralkylaminoloweralkylimide groups
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
FR2190437B1 (fr) * 1972-07-05 1975-08-08 Merieux Inst
US3926939A (en) * 1973-08-24 1975-12-16 Mikhail Ivanovich Ivanov Method of extracting pure serum albumin from biological fluids using a salt of a carboxylic aliphatic acid
DE2537123A1 (de) * 1975-08-20 1977-03-03 New Zealand Inventions Dev Verfahren zur herstellung von albumin
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2322871A1 (fr) * 1975-09-08 1977-04-01 New Zealand Inventions Dev Procede d'isolement d'albumine

Also Published As

Publication number Publication date
FR2364925B1 (fr) 1980-04-25
DE2742150A1 (de) 1978-03-23
BE858893A (fr) 1978-03-20
CH633809A5 (de) 1982-12-31
JPS6034522B2 (ja) 1985-08-09
SE442588B (sv) 1986-01-20
SE7710479L (sv) 1978-03-21
JPS5338616A (en) 1978-04-08
US4075197A (en) 1978-02-21
DE2742150C2 (fr) 1987-06-19

Similar Documents

Publication Publication Date Title
FR2364925A1 (fr) Procede de production d'albumine de serum et nouveau produit ainsi obtenu
Solomon et al. Bence-Jones proteins and light chains of immunoglobulins: I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves
Vanaman et al. The complete amino acid sequence of the acyl carrier protein of Escherichia coli
EP0317376B2 (fr) Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
KR930007434B1 (ko) 혈액응고 억제 단백질 제조방법
Becherer et al. Identification of the C3b receptor-binding domain in third component of complement.
CA1202566A (fr) Separation des proteines plasmatiques des cultures de cellules
Esmon et al. Purification of an apparent rat liver prothrombin precursor. Characterization and comparison to normal rat prothrombin
Hubbard et al. Vitamin K-dependent carboxylase: affinity purification from bovine liver by using a synthetic propeptide containing the gamma-carboxylation recognition site.
FR2358886A1 (fr) Procede de production de fractions d'albumine du serum et nouveaux produits ainsi obtenus
JPH0636741B2 (ja) ヒト・プロテインｃの分離方法
Zähringer et al. Distribution of ferritin mRNA and albumin mRNA between free and membrane-bound rat liver polysomes
KR850006550A (ko) 단백질의 제조방법
Monkovic et al. Invertebrate aspartyl/asparaginyl β-hydroxylase: potential modification of endogenous epidermal growth factor-like modules
US5171837A (en) Peptide capable of binding interleukin 6 and an adsorbent comprising the peptide immobilized on a carrier
US5077393A (en) Method for producing vitronectin
KR960013460B1 (ko) 안티-pci 모노클로날 항체
US5801037A (en) Expression of signal-peptide-free staphylokinases
KR960015745B1 (ko) 변형된 인간-psti
Wong et al. Enzymic synthesis of opioid peptides
Malm et al. Expression of completely γ‐carboxylated and β‐hydroxylated recombinant human vitamin‐K‐dependent protein S with full biological activity
JPH0780914B2 (ja) ヒト腫瘍壊死因子に対する抗体
US5188969A (en) Monoclonal antibody to human lymphotoxin and use thereof
FR2489838A1 (fr) Endoproteinase-lys-c provenant de bacteries, sa preparation et son utilisation
US5258504A (en) Process for the purification of streptolysin O, intact streptolysin O obtainable by this process

Legal Events

Date Code Title Description
ST Notification of lapse